1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Medtronic plc

Medtronic plc

MDT
Medtronic plcUS flagNew York Stock Exchange
81.32
USD
+0.94
- -
104.41BMarket Cap

Total Valuation

Medtronic plc carries a market capitalization of 104.41B, placing it among publicly traded companies globally. Its enterprise value stands at 103.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap104.41B
Enterprise Value103.80B

Valuation Ratios

Medtronic plc trades at a trailing price-to-earnings ratio of 29.18.

PE Ratio29.18
PS Ratio3.91
PB RatioN/A
P/TBV RatioN/A
P/FCF Ratio16.90
P/OCF Ratio21.82

Enterprise Valuation

On an enterprise value basis, Medtronic plc trades at an EV/EBITDA multiple of 14.71 and an EV/FCF ratio of 15.68. The EV/Sales ratio of 3.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.56 provides insight into valuation relative to core operating earnings.

EV / Sales3.91
EV / EBITDA14.71
EV / EBIT21.56
EV / FCF15.68

Financial Position

Medtronic plc maintains a current ratio of 6.96, meaning it holds 7.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 176.06, indicating elevated leverage, while an interest coverage ratio of 13.12 demonstrates strong ability to service its debt obligations.

Current Ratio6.96
Quick Ratio4.28
Debt / Equity176.06
Debt / EBITDAN/A
Interest Coverage13.12

Financial Efficiency

Medtronic plc posts a return on equity of 22.60 and a return on invested capital of 10.28.

Return on Equity (ROE)22.60
Return on Assets (ROA)7.76
Return on Invested Capital (ROIC)10.28
Return on Capital Employed (ROCE)13.23
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.41

Taxes

Over the trailing twelve months, Medtronic plc has paid 724.00M in income taxes, reflecting an effective tax rate of 16.83.

Income Tax724.00M
Effective Tax Rate16.83

Stock Price Statistics

Medtronic plc's stock has declined approximately -5.62841% over the past 52 weeks. The 50-day moving average sits at 80.49, while the 200-day moving average is 92.06.

Beta (5Y)N/A
52-Week Price Change-5.62841%
50-Day Moving Average80.49
200-Day Moving Average92.06
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Medtronic plc generated 26.56B in revenue and converted that into 3.56B in net income, yielding earnings per share of 2.78. EBITDA reached 7.06B, while operating income came in at 4.81B.

Revenue26.56B
Gross Profit17.23B
Operating Income4.81B
Pretax Income4.30B
Net Income3.56B
EBITDA7.06B
EBIT4.81B
Earnings Per Share (EPS)2.78

Cash Flow

Medtronic plc produced 4.76B in operating cash flow over the past twelve months. After subtracting -1.42B in capital expenditures, free cash flow totaled 3.34B - equivalent to 2.61 per share.

Operating Cash Flow4.76B
Capital Expenditures-1.42B
Free Cash Flow3.34B
FCF Per Share2.61

Margins

Medtronic plc operates with a gross margin of 64.89, reflecting its pricing power and cost economics. The operating margin of 18.13 and net profit margin of 13.39 provide insight into operational efficiency.

Gross Margin64.89
Operating Margin18.13
Pretax Margin16.20
Profit Margin13.39
EBITDA Margin26.57

Dividends & Yields

The company's payout ratio of 75.90 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share2.13
Dividend YieldN/A
Payout Ratio75.90
Shareholder Yield3.72
FCF Yield5.92

Stock Splits

Medtronic plc's most recent stock split took place on September 27, 1999 with a 1:2 split ratio.

Last Split Date9/27/1999
Split Ratio1:2

Scores

Medtronic plc posts an Altman Z-Score of 14.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score14.29